NEE
47
-5
CAH
47
15
HSY
31
2
NRG
59
-10
MLM
60
-7
MTB
56
-3
SYK
60
9
AEP
40
-2
CCI
25
-11
DAL
80
3
ABBV
59
-3
KR
40
3
CMG
63
9
TEL
66
16
SE
52
2
SYY
52
11
AMZN
56
5
CMI
47
-2
LNC
45
-8
TXT
53
3
NEE
47
-5
CAH
47
15
HSY
31
2
NRG
59
-10
MLM
60
-7
MTB
56
-3
SYK
60
9
AEP
40
-2
CCI
25
-11
DAL
80
3
ABBV
59
-3
KR
40
3
CMG
63
9
TEL
66
16
SE
52
2
SYY
52
11
AMZN
56
5
CMI
47
-2
LNC
45
-8
TXT
53
3
Financhill
Back

The Cooper Companies 10K Form

Buy
57

COO
The Cooper Companies

Last Price:
105.83
Seasonality Move:
5.5%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive COO News And Ratings

See the #1 stock for the next 7 days that we like better than COO

COO Financial Statistics

Sales & Book Value

Annual Sales: $3.59B
Cash Flow: $118.5M
Price / Cash Flow: 111.92
Annual Sales: $39.80
Price / Book: 2.66

Profitability

EPS (TTM): 1.79500
Net Income (TTM): $359.3M
Gross Margin: $2.36B
Return on Equity: 4.67%
Return on Assets: 3.02%

The Cooper Companies Earnings Forecast

Key The Cooper Companies Financial Ratios

  • The Gross Profit Margin over the past 40 years for COO is 65.62%.
  • The Selling, General & Administrative Expenses for COO have been equal to 41.78% of Gross Profit Margin.
  • The Research & Development expenses have been 3.82% of Revenue.
  • The Interest Expense is 35.79% of Operating Income.
  • The Net Earning history of COO is 8.19% of Total Revenues.
  • Per Share Earnings over the last 40 years have been positive in 25 years.

The Cooper Companies Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: COO
CUSIP: 216648
Website: coopercos.com

Debt

Debt-to-Equity Ratio: 0.33
Current Ratio: 1.99
Quick Ratio: 0.88

Price-to-Earnings

Trailing P/E Ratio: 71.64
Forward P/E Ratio: 23.29

COO Technical Analysis vs Fundamental Analysis

Buy
57
The Cooper Companies (COO) is a Buy

Is The Cooper Companies a Buy or a Sell?